KROS
Keros Therapeutics Inc.
$15.21
-$0.04(-0.26%)
35
Overall
--
Value
40
Tech
31
Quality
Market Cap
$605.58M
Volume
586.02K
52W Range
$9.12 - $72.37
Target Price
$23.33
Key Metrics Overview
| Market Cap | $605.58M | P/E Ratio | 46.09 |
| 52W High | $72.37 | 52W Low | $9.12 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -18.7% | 52W Position | 9.6% |
| Overall Score | 35 | Value Score | -- |
| Quality Score | 31 | Technical Score | 40 |
Growth Analysis
| EPS Current Est | $0.33 | EPS Next Est | $-4.78 |
| EPS Growth Est | -1548.5% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KROS | $15.21 | -0.3% | 586.02K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |